Skip to main content

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Introduction

On October 18, Johnson & Johnson, the U.S. healthcare conglomerate facing thousands of lawsuits over its talc-containing products, announced a voluntary recall of a single batch of its baby powder after receiving an alert from the US Food and Drug Administration (FDA) that it tested positive for asbestos, a known cancer-causing substance.

As per the statement released by the healthcare company, the FDA found sub-trace levels of chrysotile asbestos contamination at concentrations not exceeding 0.00002% in a single bottle purchased from an online retailer. The recall applies to lot #22318RB resulting in recall of 33,000 bottles of talcum powder. J&J said it has started an investigation and is reviewing manufacturing records and collecting data on the distribution of the lot to determine where the product was shipped.

Time and again J&J has defended its talcum-powder calling it safe, stating that decades of studies have shown the products to be asbestos-free and that they do not cause cancer. However, the FDA said it stands by the quality of its testing and results and recommended that consumers stop using the product if it comes from the affected lot.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!